Fainting spells often tied to too many meds at once, study says

November 5, 2012 in Medications

Fainting spells often tied to too many meds at once: study

Doctors usually work with patients to spread dosing out, to avoid such problems.

(HealthDay)—Taking too many medications at the same time could lead to repeated fainting episodes, a new study reveals.

"Simply stated, the more antihypertensive pills a patient takes, the greater the likelihood of a possible fainting spell under certain circumstances," explained one cardiologist, Dr. David Friedman, chief of Services at North Shore-LIJ's Plainview Hospital in Plainview, N.Y. He was not involved in the new research.

In the study, Danish researchers led by Dr. Martin Ruwald of Copenhagen University Hospital Gentofte looked at more than 127,000 patients, median age 64, who were hospitalized for fainting between 1997 and 2009.

Of those patients, more than one-fifth had experienced at least two fainting episodes.

The researchers found that the risk of repeat fainting rose with the number of medications that patients were taking at the same time. For example, compared with people who took no medications, recurrent fainting was 16 percent more likely for those taking one drug; 20 percent more likely for those taking two drugs; and 32 percent more likely for those taking three or more drugs, the team reported.

Ruwald's team focused on drugs known to cause a sudden drop in blood pressure when a person stands up after lying down. These drugs included widely used types of such as alpha blockers, , diuretics, and .

The study was to be presented in Los Angeles on Sunday at the annual meeting of the .

Friedman said fainting, which doctors call "syncope," isn't uncommon among .

"In my practice, patients who have demonstrated recurrent syncope or near syncope while on several blood pressure pills for various multiple health-related reasons, benefit from medication dose adjustments on a variable schedule or staggering pills at different hours along the day as needed," he said. Often, detailed discussions with patients or their caregivers allow them to adjust dosing schedules on their own based on blood pressure readings or other medical factors, Friedman added.

"I find these measures help patients adhere to potentially difficult medication regimens, maximize drug optimization, and minimize the chances of dizziness, lightheadedness, or overt passing out spells," he said.

Findings presented at medical meetings are usually considered preliminary until published in a peer-reviewed journal.

More information: The U.S. National Institute of Neurological Disorders and Stroke has more about fainting.

Copyright © 2012 HealthDay. All rights reserved.

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Medications created 15 hours ago | popularity not rated yet | comments 0

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created May 23, 2013 | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created May 23, 2013 | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.